Case Western Reserve University

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

FDA Approves VUEWAY® (gadopiclenol) Solution for Injection, Intravenous Use, for Use in Neonates and Infants

Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
BioSpace

New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...
Medscape

Gadolinium-Based Contrast Agents and Brain Safety: Signal vs Noise

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...
Becker's Hospital Review

Contrast Agent Could Help Detect Infections Through Imaging

Contrast agents could provide an efficient means for physicians to detect infections through imaging, rather than unnecessarily prescribing antibiotics, according to a Technology Review report. Two ...
News Medical

New oral contrast agent improves bowel disease detection on CT scans

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the University of California San Francisco, and Nextrast Inc. found that a new imaging ...
Business Wire

Ultrasound contrast agents may help identify uterine disorders and prostate cancers

CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...
KTVZ

New MRI contrast agent designed at OSU represents breakthrough in safer medical imaging

CORVALLIS, Ore. (KTVZ) -– Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents ...
Medscape

Gold Nanoparticles as Contrast Agents in X-ray Imaging and Computed Tomography

Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...
Becker's Hospital Review

New contrast agent lights up ‘zombie cells’

In a possible first, researchers at Stanford (Calif.) Medicine found a non-invasive imaging method to visualize senescent cells. “As we age, we accumulate senescent cells. These are like ‘zombie cells ...
Monthly Prescribing Reference

VEGFR2-Binding Contrast Agent Fast Tracked for Crohn Disease Assessment

BR55 was safe and highly accurate (>95%) at marking VEGFR2 expression in patients with breast, ovarian and thyroid cancer, as well as Crohn disease. The Food and Drug Administration (FDA) has granted ...